Back to Search

JAZZ

Jazz Pharmaceuticals, Inc.
Data: 2026-06-23
$225.325
Price
-0.26%
Change
$243.32
52W High
$105.00
52W Low
Buy/Sell Forecast Trendline Why Moving Charts Options

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Quick Stats
Jun 23, 2026

61.3

AI Score

BUY

0.07

Volume Ratio

Aug 04, 2026

Next Earnings

16

+ve Days (30d)

14

-ve Days (30d)

JAZZ Stock Summary

Last updated

JAZZ is currently trading at $225.325, positioned above its 200-day moving average of $176.02, indicating a long-term uptrend. The stock has a 52-week range of $105 to $243.32.

Technical Analysis: The 50-day moving average stands at $221.44, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads , suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is , which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates JAZZ at 61.3/100 with a BUY recommendation.

JAZZ Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

JAZZ Price vs Max Options Open Interest
JAZZ Max Change In Options Open Interest

JAZZ Options - Sort by Max open Interest (near term)

23rd June 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

JAZZ Daily Out of Money Options - Sort by Max open Interest (near term)

23rd June 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

JAZZ Daily In the Money Options - Sort by Max open Interest (near term)

23rd June 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

JAZZ Most Active Options by Volume(near term)

23rd June 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track

Jazz Pharmaceuticals, Inc. is above both 50 Day and 200 Day SMA which is considered Bullish.

JAZZ Moving Averages Analysis

Jazz Pharmaceuticals, Inc. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jun 23, 2026

Jazz Pharmaceuticals, Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jun 23, 2026

JAZZ (Jazz Pharmaceuticals, Inc.) Simple Moving Averages

Moving Averages are last updated Jun 23, 2026

Days MA
10 228.59
20 231.65
30 232.06
50 221.44
100 200.55
200 176.02

JAZZ Fundamental Analysis

P/E (Forward) 12.2549
P/E (Trailing) 2042.3636
Market Cap ($) 14.1 billion
Earnings/Share ($) 0.11
Net Proft Margin (%) 0.0066
Dividend/Share ($) --
EPS Estimate Current Year ($) 25.3886
EPS Estimate Next Year ($) 25.6115
WallStreet Target Price ($) 257
Most Recent Quarter